Comparative Long-Term Immunogenicity and Boosting of 3-Versus 4-Session Intradermal Rabies Post-Exposure Prophylaxis Regimens, Cambodia and Madagascar: The Resist-3 Study

Clicks: 17
ID: 317293
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #479 of 635 articles by views in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 635 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background The abridged Institut Pasteur du Cambodge (IPC) 3-session intradermal (ID) rabies post-exposure prophylaxis (PEP) regimen has been shown to be as safe and immunogenic as the 4-session regimen previously recommended by WHO. This regimen reduces time, cost, improves adherence and access to PEP for underserved people. Our study aimed to compare long-term and anamnestic immune response after a rabies vaccine booster dose in people previously vaccinated with a 3 or 4-session ID PEP. Methods In this prospective, multi-site, comparative immunogenicity study, we measured rabies virus neutralizing antibody in 181 persons that had previously received 3- or 4-session ID PEP, 2, 5, or 10 years earlier in Cambodia or Madagascar, at day 0 and at day 7 after a booster. In addition, RABV-specific T cell response was evaluated in a sub-group of 35 Cambodian participants. Results All participants had rabies virus neutralizing antibody titers considered adequate (≥ 0.5 IU/mL) on day 7 after the booster dose. The overall geometric mean titer (GMT) of rabies antibody on day 0 and day 7 did not differ significantly between the 2 groups. Furthermore, RABV-specific T cell response was similar regardless of the ID PEP regimen initially received in a sub-group of 35 participants. Conclusions In this multisite, real-world study, we showed that the 3-session ID PEP regimen provides robust long-term immunogenicity up to 10 years after initial PEP and ensures the induction of an adequate anamnestic response within 7 days after an additional booster in all participants.
Reference Key
openalex_W7164866695 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Perrine Parize, Sothy Touch, Vaomalala Raharimanga, Nisa Ya, Katherine E. L. Worsley‐Tonks, Lauriane Kergoat, Pisey Thai, Soa Fy Andriamandimby, Saraden In, Anou Dreyfus, Malen Chan, Mino Harimbola Razafindramparany, Veasna Duong, Ravo Ramiandrasoa, Yiksing Peng, Tineke Cantaert, Philippe Dussart, Guilherme Dias de Melo, Sowath Ly, Rindra Vatosoa Randremanana, Arnaud Tarantola, Hervé Bourhy
Are you one of these authors? Claim your profile
Journal Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Year 2026
DOI
10.1093/cid/ciag368
URL
https://doi.org/10.1093/cid/ciag368
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.